FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Novel Laboratories, Inc. d.b.a Lupin Somerset Peg-3350 Recall

PEG-3350, Sodium Sulfate, Sodium Chloride, Potassium Chloride, Sodium Ascorbate, and As…

Novel Laboratories, Inc. d.b.a Lupin Somerset · Somerset, NJ

Risk level
Class III
Reported by FDA
Aug 14, 2024
Recall ID
D-0628-2024
Check your lot numberHow we source this data

Summary

Novel Laboratories, Inc. d.b.a Lupin Somerset recalled Peg-3350 starting Jul 2, 2024. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0628-2024 on Aug 14, 2024. Reason: Defective container: potential for non-sealed pouches which can lead to product leakage. Status: Terminated.

Why it was recalled

Defective container: potential for non-sealed pouches which can lead to product leakage.

Product description

PEG-3350, Sodium Sulfate, Sodium Chloride, Potassium Chloride, Sodium Ascorbate, and Ascorbic Acid for Oral Solution 100g/7.5 g /2.691 g/1.015 g/ 5.9 g / 4.7 g, 3 pouches/carton, Rx only, Distributed by: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC# 0093-3560-26.

Lot numbers, UPCs & expiration codes

Lot #S300542, exp. date June 30, 2025

Where it was sold

Nationwide in the US.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0628-2024
Classification
Class III
Status
Terminated
Recall initiated
Jul 2, 2024
FDA report date
Aug 14, 2024
Quantity
13,200 cartons
Recall type
Voluntary: Firm initiated
Recalling firm
Novel Laboratories, Inc. d.b.a Lupin Somerset

Original FDA data

Every field from FDA enforcement report D-0628-2024, exactly as published.

Show all FDA fields
City
Somerset
State
NJ
Status
Terminated
Country
United States
Event ID
94924
Address
400 Campus Dr
Code information
Lot #S300542, exp. date June 30, 2025
Postal code
08873-1145
Report date
Aug 14, 2024
Product type
Drugs
Recall number
D-0628-2024
Classification
Class III
Recalling firm
Novel Laboratories, Inc. d.b.a Lupin Somerset
Product quantity
13,200 cartons
Termination date
Apr 28, 2025
Reason for recall
Defective container: potential for non-sealed pouches which can lead to product leakage.
Voluntary / mandated
Voluntary: Firm initiated
Product description
PEG-3350, Sodium Sulfate, Sodium Chloride, Potassium Chloride, Sodium Ascorbate, and Ascorbic Acid for Oral Solution 100g/7.5 g /2.691 g/1.015 g/ 5.9 g / 4.7 g, 3 pouches/carton, Rx only, Distributed by: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC# 0093-3560-26.
Distribution pattern
Nationwide in the US.
Recall initiation date
Jul 2, 2024
Initial firm notification
Letter
Center classification date
Aug 7, 2024

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0628-2024, published Aug 14, 2024. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls